Metformin and Prostate Cancer: a New Role for an Old Drug
[h=3]Summary[/b]While the body of evidence to support a role for metformin in prostate cancer therapy is rapidly growing, there is still insufficient data from randomised trials, which are currently still ongoing. However, evidence so far suggests metformin could be a useful adjuvant agent, particularly in patients on ADT.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405102/
